Disease | hypercholesterolemia, familial |
Comorbidity | C0042373|vascular disease |
Sentences | 7 |
PubMedID- 20156339 | A tailored lifestyle intervention to reduce the cardiovascular disease risk of individuals with familial hypercholesterolemia (fh): design of the pro-fit randomised controlled trial. |
PubMedID- 20169164 | Background: the risk of premature cardiovascular disease in patients with familial hypercholesterolemia (fh) can be profoundly reduced by cholesterol-lowering therapy, and current guidelines for fh advocate ambitious low-density lipoprotein cholesterol (ldl-c) goals. |
PubMedID- 25525746 | We investigated whether anxa5 genetic variations and plasma anxa5 levels were associated with carotid atherosclerosis and contributed to cardiovascular disease (cvd) risk in patients with familial hypercholesterolemia (fh). |
PubMedID- 22119890 | The logarithm of the triglyceride/hdl-cholesterol ratio is related to the history of cardiovascular disease in patients with familial hypercholesterolemia. |
PubMedID- 22819221 | Lrp1 gene polymorphisms are associated with premature risk of cardiovascular disease in patients with familial hypercholesterolemia. |
PubMedID- 23882283 | familial hypercholesterolemia (fh) is associated with premature atherosclerotic cardiovascular diseases, and is inherited as an autosomal dominant trait. |
PubMedID- 25029472 | Association of peripheral arterial and cardiovascular diseases in familial hypercholesterolemia. |
Page: 1